Starting May 1, 2024, we will require prior authorization for the following newly added medications.
For Monument One, Colorado Doctors Plan, Rocky Mountain Valley Health Plan, Rocky Mountain Sky Plan, Sky Colorado Option and Monument Health plans:
Medication | HCPCS code |
---|---|
Acthar® Gel (repository corticotropin injection) | J0801 |
Asceniv™ (immune globulin intravenous [human]) | J1554 |
Briumvi™ (ublituximab-xiiy) | J2329 |
Purified Corticotropin™ Gel (repository corticotropin) | J0802 |
Qalsody™ (tofersen) | J1304 |
For Rocky Mountain Health Plans Medicaid PRIME and CHP+ plans:
Medication | HCPCS code |
---|---|
Aduhelm™ (aducanumab) | J0172 |
For Rocky Mountain HealthPlans CareAdvantage Value, Rocky Mountain CareAdvantage Enhanced (UnitedHealthcare© Medicare Advantage), and UnitedHealthcare Rocky Mountain Dual Complete CO-S003 (HMO-POS D-SNP) plans:
Medication | HCPCS code |
---|---|
Fulphila® (pegfilgrastim-jmdb) | Q5108 |
Qalsody™ (tofersen) | J1304 |
We will complete prior authorization reviews according to state-defined requirements. You’ll receive notifications of the case determination, including appeal rights, when applicable, within required time frames.
If you don’t provide sufficient clinical information, we may deny your prior authorization request. To help avoid denials, please include all documentation when submitting your prior authorization requests, according to applicable health plan protocols.
Chat with us 7 a.m.–7 p.m. CT, Monday–Friday from the UnitedHealthcare Provider Portal. You can also call us at 888-397-8129 8 a.m.–5 p.m. local time, Monday–Friday or email us at specialtyguidanceprogram@optum.com.
PCA-1-24-00125-Clinical-NN_01162024